Omentin-1 vs Cetrorelix
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Cetrorelix (Cetrorelix acetate) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Omentin-1 | Cetrorelix |
|---|---|---|
| Category | Diabetes & Metabolic | Sexual Health |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Cetrorelix acetate |
| Molecular Weight | ~35 kDa | 1431.06 Da |
| Half-Life | hours | ~30 hours |
| Amino Acids | 313 | 10 |
| Typical Dose | No approved human dose; research use only | 0.25 mg SC daily |
| Route | IV|SC | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 82 | 300 |
| Research Status | Pre-clinical | Clinical |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Cetrorelix Benefits
- ✓prevents premature ovulation
- ✓supports IVF cycle control
- ✓blocks LH surge
- ✓short-acting pituitary suppression
Omentin-1 Dosing
not established|not established
Cetrorelix Dosing
0.25 mg SC daily|start on stimulation day 5-6|protocol-dependent antagonist cycle
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Cetrorelix Side Effects
- ⚠injection-site reactions
- ⚠headache
- ⚠nausea
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Cetrorelix
Cetrorelix is a cornerstone GnRH antagonist in assisted reproduction, with a fast onset and reversible suppression of LH. Trials show it improves cycle management by reducing premature ovulation during stimulation.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.